A9517 HCPCS code: Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie
A9517 is the HCPCS Level II code for iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie. In 2024 Medicare paid an average of $33.89 per service for A9517 across 13,991 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 200 per day on outpatient hospital claims. Medicare volume fell 29% from 2022 to 2024 (19,656 to 13,991 services). In 2024, about 112 clinicians billed Medicare for A9517 for 239 beneficiaries; Arizona, California, Florida accounted for 71% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2003-01-01 |
| Last action effective | 2025-01-01 |
Who bills A9517 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 112 |
| Medicare beneficiaries | 239 |
| States with claims | 9 |
| Share of services in top 3 states (Arizona, California, Florida) | 71% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9517, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 19,656 | 332 | $33.30 | $26.53 |
| 2023 | 13,373 | 244 | $42.61 | $33.96 |
| 2024 | 13,991 | 239 | $42.56 | $33.89 |
States with the most A9517 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 2,857 | $32.21 |
| California | 2,642 | $26.93 |
| Florida | 1,611 | $24.44 |
| Louisiana | 1,272 | $17.46 |
| New York | 1,144 | $100.88 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 200 | Clinical: Society Comment |
| practitioner claims | 200 | Clinical: Society Comment |
What changed for A9517
- 2003-01-01: A9517 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9517?
A9517 is the HCPCS Level II code for iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie. Short descriptor: "I131 iodide cap, rx".
How much does Medicare pay for A9517?
In 2024, the average Medicare payment was $33.89 per service (average allowed $42.56).
Does Medicare cover A9517?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of A9517 can be billed per day?
200 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9517
- Watch A9517 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9517
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.